Prevention of Meningitis
Cochlear Implants and Inner Ear Abnormalities
Arch Otolaryngol Head Neck Surg. 2003;129:279-281.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
INTRODUCTION
RECENTLY, the Food and Drug Administration (FDA) issued a Public Health Web Notification that recipients of cochlear implants are at risk for meningitis.1 The FDA noted that 91 cases of meningitis were reported worldwide in patients who received implants, and a total of 17 known deaths resulted from this infection. Most patients were younger than 7 years, but some adults also developed meningitis; among the 52 cases reported from the United States, the age at onset ranged from 18 months to 84 years. The pathogenesis of the episodes of meningitis remains uncertain, but the design of the implant and the surgical technique may be factors. Also, importantly, the FDA recognizes that some deaf patients who are implant recipients may have congenital malformations of the inner ear that would increase their risk for meningitis; children with inner ear anomalies have successfully undergone implantation.2 The manufacturers of the implants and implant surgeons . . . [Full Text of this Article]
METHODS OF PREVENTION
Surgery Vaccines
RECOMMENDATIONS AND CONCLUSIONS
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Group A Streptococcal Meningitis in a Pediatric Patient following Cochlear Implantation: Report of the First Case and Review of the Literature
Pettersen et al.
J. Clin. Microbiol. 2005;43:5816-5818.
ABSTRACT
| FULL TEXT
Bacterial Meningitis in Children with Cochlear Implants
Lefrancois et al.
NEJM 2003;349:1772-1773.
FULL TEXT
|
